FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Trokendi XR (topiramate) from Supernus Pharmaceuticals, indicating an update to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• TROKENDI XR (TOPIRAMATE)

Snippet

SUPPL AP for TROKENDI XR (TOPIRAMATE)